159 related articles for article (PubMed ID: 37965304)
1. Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies.
Ren Y; Chen S; Yang H
Front Immunol; 2023; 14():1279808. PubMed ID: 37965304
[TBL] [Abstract][Full Text] [Related]
2. Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody.
Bai Y; Li W; Yan C; Hou Y; Wang Q
Front Immunol; 2023; 14():1121705. PubMed ID: 37056784
[TBL] [Abstract][Full Text] [Related]
3. Case report: Autoimmune nodopathy with concurrent serum and CSF IgG4 anti-neurofascin 155 antibodies.
Wang W; Liu L; Zhang M; Yang R; Liu D; Yang S; Meng Q
Front Immunol; 2022; 13():1028282. PubMed ID: 36248836
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of patients with autoimmune nodopathy with anti-neurofascin155 antibodies.
Zhang J; Hou X; Wei L; Liu J; Li S; Guo Y; Liu H; Jiang Y
Front Immunol; 2024; 15():1345953. PubMed ID: 38726012
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
Martín-Aguilar L; Lleixà C; Pascual-Goñi E; Caballero-Ávila M; Martínez-Martínez L; Díaz-Manera J; Rojas-García R; Cortés-Vicente E; Turon-Sans J; de Luna N; Suárez-Calvet X; Gallardo E; Rajabally Y; Scotton S; Jacobs BC; Baars A; Cortese A; Vegezzi E; Höftberger R; Zimprich F; Roesler C; Nobile-Orazio E; Liberatore G; Hiew FL; Martínez-Piñeiro A; Carvajal A; Piñar-Morales R; Usón-Martín M; Albertí O; López-Pérez MÁ; Márquez F; Pardo-Fernández J; Muñoz-Delgado L; Cabrera-Serrano M; Ortiz N; Bartolomé M; Duman Ö; Bril V; Segura-Chávez D; Pitarokoili K; Steen C; Illa I; Querol L
Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34728497
[TBL] [Abstract][Full Text] [Related]
6. Clinical Features of Autoimmune Nodopathy With Anti-Neurofascin-155 Antibodies in South Koreans.
Lyou HJ; Chung YH; Kim MJ; Kim M; Jeon MY; Kim SW; Shin HY; Kim BJ
J Clin Neurol; 2024 Mar; 20(2):186-193. PubMed ID: 38171501
[TBL] [Abstract][Full Text] [Related]
7. Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease.
Shi F; Xue R; Zhou X; Shen P; Wang S; Yang Y
Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):666-673. PubMed ID: 34519594
[TBL] [Abstract][Full Text] [Related]
8. Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Fujita A; Ogata H; Yamasaki R; Matsushita T; Kira JI
J Neurol Sci; 2018 Jan; 384():107-112. PubMed ID: 29249367
[TBL] [Abstract][Full Text] [Related]
9. Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy.
Wang L; Pan J; Meng H; Yang Z; Zeng L; Liu J
Brain Sci; 2022 Nov; 12(11):. PubMed ID: 36421911
[TBL] [Abstract][Full Text] [Related]
10. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.
Shelly S; Klein CJ; Dyck PJB; Paul P; Mauermann ML; Berini SE; Howe B; Fryer JP; Basal E; Bakri HM; Laughlin RS; McKeon A; Pittock SJ; Mills J; Dubey D
Neurology; 2021 Dec; 97(24):e2392-e2403. PubMed ID: 34635556
[TBL] [Abstract][Full Text] [Related]
11. Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy.
Kmezic I; Press R; Glenewinkel H; Doppler K; Appeltshauser L
J Neuroimmunol; 2024 Apr; 389():578326. PubMed ID: 38422690
[TBL] [Abstract][Full Text] [Related]
12. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
[TBL] [Abstract][Full Text] [Related]
13. Clinical profile of autoimmune nodopathy with anti-neurofascin 186 antibody.
Liu B; Zhou L; Sun C; Wang L; Zheng Y; Hu B; Qiao K; Zhao C; Lu J; Lin J
Ann Clin Transl Neurol; 2023 Jun; 10(6):944-952. PubMed ID: 37060203
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy.
Tan CY; Goh KJ; Oh AW; Devaux J; Shahrizaila N
Neuromuscul Disord; 2022 Mar; 32(3):255-262. PubMed ID: 35183410
[TBL] [Abstract][Full Text] [Related]
15. Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis.
Hu W; Xin Y; He Z; Zhao Y
Brain Behav; 2018 Oct; 8(10):e01115. PubMed ID: 30240176
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal cytokine profile in neuropathy with anti-neurofascin 155 antibody.
Ogata H; Zhang X; Yamasaki R; Fujii T; Machida A; Morimoto N; Kaida K; Masuda T; Ando Y; Kuwahara M; Kusunoki S; Nakamura Y; Matsushita T; Isobe N; Kira JI
Ann Clin Transl Neurol; 2019 Nov; 6(11):2304-2316. PubMed ID: 31657126
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study.
Liu B; Hu J; Sun C; Qiao K; Xi J; Zheng Y; Sun J; Luo S; Zhao Y; Lu J; Lin J; Zhao C
J Neurol; 2023 Sep; 270(9):4288-4295. PubMed ID: 37195346
[TBL] [Abstract][Full Text] [Related]
18. Refractory lupus hepatitis successfully treated with telitacicept who failed to belimumab: A case report and literature review.
Fan Q; Ji H; Liu Y; Jia C; Zou L; Yang H
Lupus; 2024 Apr; 33(4):414-419. PubMed ID: 38320748
[No Abstract] [Full Text] [Related]
19. Anti-neurofascin 155 Antibody-positive Neuropathy in a Human Immunodeficiency Virus-infected Patient.
Okubo S; Mano T; Sudo A; Goto R; Yano S; Hara M; Ishiura H; Satake W; Yanagimoto S; Ogata H; Toda T
Intern Med; 2024 Feb; 63(4):565-569. PubMed ID: 37380455
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment with telitacicept, cyclophosphamide and glucocorticoids for severe Granulomatous polyangiitis: a case report and literature review.
Huang L; Lin W; Liu Y; Zhu J; Li Y; Zheng Z; Tang C
Front Immunol; 2023; 14():1298650. PubMed ID: 38106422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]